|Articles|June 1, 2019
- Applied Clinical Trials-06-01-2019
- Volume 28
- Issue 6
Applied Clinical Trials, June 2019 Issue (PDF)
Click the title above to open the Applied Clinical Trials June 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Master Protocol Guidance in Cancer R&D: Impact on Industryabout 7 years ago
The Benefits of RWD & RWE in Oncology Trialsabout 7 years ago
Glimpsing the Future of Clinical Trial Designover 7 years ago
FDA Facilitates Expanded Access for Cancer Drugsover 7 years ago
News Notesover 7 years ago
Navigating Drug Development Through More Turbulent Watersover 7 years ago
Building a Physician Referral Network: A Case Studyover 7 years ago
Reveling in 2018's Revealing Drug and Biologic ApprovalsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What It Actually Means to Embed the Patient Voice in Trial Design
2
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
3
ACT Brief: Explainable AI for Patient Subgroups, Participant Understanding and Engagement, and FDA Leadership Stabilization
4
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
5